Pediatric acute respiratory distress syndrome (ARDS) manifests clinically a
s acute respiratory failure with hypoxemia requiring ventilatory assistance
. The pathogenesis of pediatric ARDS remains controversial. Among the many
causes the most common is lower respiratory tract infection, usually due to
a virus. There is general agreement that trauma related to assisted ventil
ation adds to or perpetuates the initial alveolocapillary insult. In patien
ts without immunodepression or failure of other organs, the prognosis of pe
diatric ARDS has probably been improved by recent advances in ventilatory a
ssistance techniques used in pediatric intensive care units. All cause mort
ality remains between 30% and 50%. The managment of pediatric ARDS is discu
ssed in the light of current pathophysiological concepts. Prospects for fut
ure therapeutic improvements are outlined.